Malignant Melanoma – A Single Institutional Analysis On Real World Data

Autor: Sakthi Usha Devi J, Prasanna Srinivasa Rao H, Balamurugan T.D., Muhammed Owaise J

Publikováno v: SVU - International Journal of Medical Sciences, Vol 6, Iss 2, Pp 56-67 (2023)

Background: There are very limited studies on survival analyses of malignant melanoma from the rural and southern part of India and hence we present our retrospective analyses on treatment outcomes of patients diagnosed as Malignant Melanoma from our

Externí odkaz: https://doaj.org/article/7a6ca7c1c7344bb599832183e55e473b

Rare Oral Mucosal Lesion—Extramedullary Plasmacytoma.

Autor: Sakthi Usha Devi, J, Balamurugan, T D, Prasanna Srinivasa Rao, H, Ajay Kumar, A

Publikováno v: Indian Journal of Surgery; Dec2023, Vol. 85 Issue 6, p1471-1474, 4p

RATIO OF SERUM CA125 TO RADIOLOGICAL PERITONEAL CARCINOMATOUS INDEX AS A NOVEL MARKER OF RESPONSE TO NEO ADJUVANT CHEMOTHERAPY AND PREDICTIVE MODEL OF SURGICAL OUTCOME IN ADVANCED EPITHELIAL OVARIAN CANCER- A SINGLE INSTITUITIONAL STUDY

Autor: N. Roobalakshmi Dr, Prasanna Srinivasa Rao H Dr, Prem Kumar Devdoss Dr

Publikováno v: INDIAN JOURNAL OF APPLIED RESEARCH. :1-3

Objective: The objective of this retrospective study is to develop a novel marker- ratio of serum CA 125 to peritoneal carcinomatous index(PCI) - to predict the response in women receiving neoadjuvant chemotherapy for newly diagnosed advanced epithel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33654f1ed5272949ac976d1182784917
https://doi.org/10.36106/ijar/5408387

Axillary dissection for breast cancer using electrocautery versus ultrasonic dissectors: A prospective randomized study.

Autor: Shanmugam, Subbiah, Govindasamy, Gopu, Hussain, Syed Afroze, Prasanna Srinivasa Rao H., Rao, Prasanna Srinivasa H

Publikováno v: Indian Journal of Cancer; Jul-Sep2017, Vol. 54 Issue 3, p543-546, 4p

Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.

Autor: Arunkumar G; Department of Genetics, Dr. A.L.M. PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600113, India., Deva Magendhra Rao AK; Department of Genetics, Dr. A.L.M. PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600113, India., Manikandan M; Department of Genetics, Dr. A.L.M. PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600113, India., Prasanna Srinivasa Rao H; Center for Oncology, Royapettah Government Hospital and Kilpauk Medical College, Royapettah, Chennai 600014, India., Subbiah S; Center for Oncology, Royapettah Government Hospital and Kilpauk Medical College, Royapettah, Chennai 600014, India., Ilangovan R; Department of Endocrinology, Dr. A.L.M. PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600113, India., Murugan AK; Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia., Munirajan AK; Department of Genetics, Dr. A.L.M. PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600113, India.

Publikováno v: Oncology letters [Oncol Lett] 2018 Jan; Vol. 15 (1), pp. 649-657. Date of Electronic Publication: 2017 Oct 31.